After receiving a significant regulatory approval, ImmunityBio, Inc. (NASDAQ: IBRX) saw a sharp rise in the value of its shares. IBRX shares rose 18.25% to
Pre-market trading for ImmunityBio, Inc. (NASDAQ: IBRX) shows a noteworthy continuation of the company’s current rising trend. As of the last check, IBRX stock was
The stock of ImmunityBio, Inc. (NASDAQ: IBRX) is experiencing a notable surge, exhibiting a substantial uptick of 7.94% during the current trading session, reaching $5.33.
The stock of ImmunityBio, Inc. (IBRX) gained in the after-hours when the company announced its promising results for its study. IBRX values at around $6.20,
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.